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Solute carrier (SLC) transporters mediate the uptake of biologically
active compounds in the intestine. Reduced oxygenation (hypoxia) is
an important factor influencing intestinal homeostasis. The aim of this
study was to investigate the pathophysiological consequences of
hypoxia on the expression and function of SLCs in human intestine.
Hypoxia was induced in human intestinal epithelial cells (IECs) in
vitro (0.2; 1% O2 or CoCl2). For human in vivo studies, duodenal
biopsies and serum samples were obtained from individuals (n  16)
acutely exposed to 4,554 meters above sea levels. Expression of
relevant targets was analyzed by quantitative PCR, Western blotting,
or immunofluorescence. Serum levels of inflammatory mediators and
nucleosides were determined by ELISA and LC/MS-MS, respec-
tively. In the duodenum of volunteers exposed to high altitude we
observed decreased mRNA levels of apical sodium-dependent bile
acid transporter (ASBT), concentrative nucleoside transporters 1/2
(CNT1/2), organic anion transporting polypeptide 2B1 (OATP2B1),
organic cation transporter 2 (OCTN2), peptide transporter 1 (PEPT1),
serotonin transporter (SERT), and higher levels of IFN-, IL-6, and
IL-17A. Serum levels of IL-10, IFN-, matrix metalloproteinase-2
(MMP-2), and serotonin were elevated, whereas the levels of uridine
decreased upon exposure to hypoxia. Hypoxic IECs showed reduced
levels of equilibrative nucleoside transporter 2 (ENT2), OCTN2, and
SERT mRNAs in vitro, which was confirmed on the protein level and
was accompanied by activation of ERK1/2, increase of hypoxia-
inducible factor (HIF) proteins, and production of IL-8 mRNA.
Costimulation with IFN- and IL-6 during hypoxia further decreased
the expression of SERT, ENT2, and CNT2 in vitro. Reduced oxygen
supply affects the expression pattern of duodenal SLCs that is accom-
panied by changes in serum levels of proinflammatory cytokines and
biologically active compounds demonstrating that intestinal transport
is affected during systemic exposure to hypoxia in humans.
solute carrier; intestine; hypoxia; inflammation
PHYSIOLOGICAL RESPONSE TO hypoxia is one of the most evolu-
tionary conserved adaptive mechanisms in humans (48). It is
initiated by the drop of oxygen concentration and recognized
by well-characterized hypoxia-inducible factors (HIFs) present
in every cell. Once stabilized and heterodimerized, these tran-
scription factors bind to hypoxia-responsive elements (HRE)
followed by either induction or repression of gene expression
(17, 24). Hypoxia-induced responses are initiated at a cellular
level and propagated onto tissue and eventually to systemic
levels. Numerous targets associated with response to hypoxia
have been identified and validated. They are typically associ-
ated with generation of ATP, oxidative stress, iron absorption,
and immune responses (3, 4, 19, 32, 37, 39, 42, 50).
Not surprisingly, hypoxia plays an important role also in
intestinal (patho)physiology. In a steady state, the intestinal
wall is exposed to a steep oxygen gradient reaching from
highly oxygenated submucosa to the almost anoxic intestinal
lumen; because of this phenomenon, intestinal epithelial cells
(IECs) are to some extent permanently facing “physiological
hypoxia” (9). In concert with this notion, it has been reported
that both intestinal absorption and permeability are affected by
oxygen concentration (30, 31). It is known that electrical
currents decrease rapidly in hypoxic conditions, specifically
when applied from serosal side of intestinal tissue (7). This
implies that the ion transport across gut epithelium depends on
the local oxygen concentration. Interestingly, in some patho-
logical conditions such as colitis, the inflammatory microenvi-
ronment induces hypoxic signaling, a phenomenon generally
described as “inflammatory hypoxia” (9, 14). The activation of
proinflammatory signaling in the hypoxic environment occurs
via mutual interplay between HIF-1 and NF-B transcription
factors (5) that subsequently leads to the release of proinflam-
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matory mediators as described in both in vitro (46) and in vivo
studies (27). The presence of these mediators is an important
feature of intestinal inflammation as demonstrated earlier (49).
Solute carrier (SLC) transporters mediate the uptake of a
large variety of nutrients, ions, and biologically active com-
pounds across plasma membranes and organelles. The biolog-
ical significance of these proteins is high since they participate
in important processes such as differentiation, absorption,
stress, inflammation, neurotransmission, and metabolism (29).
In the intestine, solute carriers are predominantly expressed in
the IECs, but some of them also in other cell types, including
immune cells (35). It has been demonstrated that oxygen
deprivation affects the intestinal iron absorption via HIF-2-
dependent mechanisms (23, 32, 54). In addition, the expression
levels of equilibrative nucleoside transporters in IECs are
suppressed by hypoxia and this phenomenon may have a direct
effect on the attenuation of inflammation in the gut (13, 36). It
has been shown earlier that low oxygen levels can decrease the
levels of carnitine transporter organic cation transporter
(OCTN) 2 (8, 40) as well as cystic fibrosis transmembrane
conductance regulator (CFTR) (56). Despite the fact that these
studies were performed in specific pathological settings, they
can provide some indications about the control of other immu-
nologically and physiologically relevant intestinal SLC trans-
porters during hypoxia in humans.
Previously, we reported that the mRNA expression levels of
SLCs are altered in patients with inflammatory bowel diseases
(IBD) (52). In the present study we investigated the impact of
hypoxia on expression and function of specific subset of
physiologically relevant intestinal SLC transporters and proin-
flammatory responses in the gut. We observed that both hy-
poxia-driven changes in the intestinal SLCs and proinflamma-
tory signaling are coexisting events and can provide insights
into the novel, immunologically relevant adaptive mechanisms
to oxygen deprivation in the intestine.
MATERIALS AND METHODS
Human subjects and exposure to high-altitude hypoxia. Description
of human subjects and the study design for high-altitude hypoxia was
given in detail elsewhere (2, 44); the study was approved by the Ethics
Committee of the Canton of Zurich (EK-1677). Briefly, after blood
and biopsy sampling at the University Hospital Zurich (USZ), healthy
individuals (n  16) ascended to the Capanna Regina Margherita
(CM; 4,559 m above sea level) where both duodenal biopsies and
peripheral blood were taken at days 2 and 4 after ascent to high
altitude. Acute mountain sickness (AMS) was diagnosed in some
subjects using the Lake Louise Score (LLS 5) accompanied by
medical examination. These individuals (n  8) were given dexa-
methasone (9-fluor-16a-methylprednisolone, dexamethasone; Galep-
harm, Kuesnacht, Switzerland) at 2  8 mg/day as soon as the AMS
symptoms appeared (after all samples were collected on day 2) and
distinguished retrospectively from the control group (n  8) during
analysis of duodenal and serum targets. All biological specimens were
stored and transported in liquid nitrogen until the analysis in the
laboratory of Gastroenterology and Hepatology of USZ.
Antibodies, chemicals, Taqman assays, and recombinant cytokines.
Rabbit anti-phospho Akt (no. 4058), rabbit anti-Akt (no. 9272), rabbit
anti-phospho p44/42 (no. 9101), rabbit anti-p44/42 (no. 4695), rabbit
anti-p38 (no. 9212), rabbit anti-STAT1 (no. 9172), and rabbit anti--
actin (no. 4970) antibodies were purchased from Cell signaling
(Danvers, MA). Rabbit anti-ENT2/SLC29A2 (ARP43822) and rabbit
anti-OCTN2/SLC22A5 (ARP63404) antibodies were obtained from
Aviva Systems Biology (San Diego, CA). Rabbit anti-human SERT/
SLC6A4 (BS-1893R) was purchased from Bioss (Woburn, MA).
Rabbit anti-HIF-1 antibody (NB100–479) was obtained from Novus
Biologicals (Littleton, CO). Mouse anti-HIF-2 was purchased from
Abcam (Cambridge, UK). Human recombinant IFN- (IFG40012)
and IL-6 (I1395), and CoCl2 (15862) were purchased from Sigma-
Aldrich (Buchs, Switzerland). FM19G11 (sc-364490) and FR180204
(sc-203945) were obtained from Santa Cruz Biotechnology (Dallas,
TX, USA). -actin (4310881E), GLUT-1 (Hs00892681_m1), IFN-
(Hs00989291_m1), and IL-6 (Hs00174131_m1) Taqman assays were
purchased from Applied Biosystems (Foster City, CA). All Taqman
assays used for detection of duodenal SLC transporters and villin-1 by
RT-PCR were identical with those used in our previous studies (34, 52).
Quantification of chemokines, cytokines, and other metabolites in
human serum. The analysis of the cytokine content in serum samples
of at least six human subjects was completed at Rules-Based Medicine
(Austin, TX) using Human Cytokine MAP A 1.0 array. Serotonin
concentration in serum samples of at least six human subjects was
determined using Serotonin Research ELISA purchased from Rocky
Mountains Diagnostics (BA E-5900; Colorado Springs, CO) accord-
ing to the manufacturer’s protocol. The levels of total bile acids were
quantified by colorimetric assay (BQ 092A-EALD; BQKits Diagnos-
tics, San Diego, CA).
Cultivation of IECs. Human epithelial intestinal cell line T84 were
cultivated at 37°C in a 5% CO2 incubator in high-glucose DMEM
medium (Sigma-Aldrich) containing L-glutamine, sodium bicarbon-
ate, and 10% FCS. T84 cells were obtained from American Type
Culture Collection (ATCC, Manassas, VA).
RNA isolation, RT-PCR, and analysis of data. Frozen tissues were
lysed in RLT buffer containing DTT and processed by QIACUBE
(Qiagen, Hilden, Germany) according to the manufacturer’s protocol.
Reverse transcription was performed using RT kit (Life Sciences,
Zug, Switzerland) according to the manufacturer’s protocol. RT-PCR
analysis of target genes was performed relatively to the expression of
either villin-1 (SLC transporters) or -actin (other targets) as house-
keeping genes. The expression levels of targets for human mRNA
expression levels were assessed by setting the expression levels of ground
level (Zurich, 400 m above sea level) to 1. The expression of housekeep-
ing genes was measured in triplicates and the levels of other targets in
duplicates for each duodenal specimen. For experiments with cell lines,
the measurements were performed in duplicates for every target.
Induction of hypoxia and stimulation with cytokines. To induce
hypoxia in T84 cells, we used hypoxic chambers. Briefly, cells were
plated on Polyester (PET) Membrane Transwell-Clear Inserts (3470;
Costar; Sigma-Aldrich) for 4 wk. Afterwards cells were incubated in
either 0.2 or 1% of O2 (5% CO2) hypoxic chambers (InVivo400,
Ruskinn, Bridgend, UK) in standard cultivation medium (Sigma-
Aldrich) for the indicated time points. For costimulation with proin-
flammatory cytokines, both IL-6 and IFN- were added to the basal
chamber at the concentration of 50 ng/ml 24 h before harvesting.
Alternatively, to induce hypoxia chemically, T84 cells were stimu-
lated with different concentrations of CoCl2 (Sigma-Aldrich) in stan-
dard cell culture incubator for 48 h as described elsewhere (51).
Cell lysis and protein determination. Cells were scraped from the
Transwells in the presence of ice-cold M-PER buffer (Pierce,
Wohlen, Switzerland) containing 1 mM DTT and cocktail of
protease inhibitors (Roche, Basel, Switzerland). Protein concentra-
tions in the cell lysates were determined using the BCA Protein
Assay Reagent (Pierce). Cell lysates containing 10 	g of total
protein were suspended in NuPAGE LDS Sample Buffer (Life
Sciences) containing 50 mM DTT.
SDS electrophoresis and Western blotting. Proteins were separated
in 10% polyacrylamide gel (Tris/glycine) and transferred onto nitro-
cellulose membranes. Before incubation with primary antibodies,
membranes were blocked with 5% solution of nonfat dried milk buffer
in TBS-T (TBS 
 0.1% Tween) for 1 h at room temperature (RT)
with gentle shaking. Primary antibodies were diluted in TBS-T con-
taining 5% BSA and incubated with the membranes overnight at 4°C.
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Corresponding secondary antibodies were diluted in TBS-T buffer
containing 5% blocking milk for 1 h at RT. Bands were detected by
using ECL detection kit (GE Healthcare, Glattbrugg, Switzerland).
Immunofluorescence. T84 cells were grown on Transwells until full
confluence and incubated in hypoxic chambers for indicated time
points. Monolayers were then fixed with 4% PFA for 30 min,
permeablized with 0.1% Triton X-100 for 15 min, and blocked with
5% BSA for 1 h at RT. Primary antibodies were applied overnight at
4°C followed by respective secondary ABs 1 h at RT. Monolayers
were mounted on glass slides using Dako mounting medium.
Cell viablility, proliferation, and cytotoxicity assays. T84 cells
were grown on 96-well plates to reach 80% confluency. LDH
release assay (11644793001) purchased at Roche as well as cell
proliferation (G3582) and cell viability assay (G9241) purchased at
Promega (Dubendorf, Switzerland) were performed in according to
the manufacturers’ protocols.
Quantification of uridine and hypoxanthine in serum. Serum uri-
dine and hypoxanthine were measured by liquid chromatography
coupled to tandem mass spectrometry using an Acquity UPLC-Xevo
TQ Mass Spectrometer (Waters, Milford, MA). Two-hundred micro-
liters of serum samples were deproteinized by addition of 9 	l of
perchloric acid 11.6 M (final concentration 0.5 M) and centrifuged at
20,000 g and 4°C for 10 min. Then, 5 	l of supernatant were injected
into the UPLC-MS/MS apparatus. The stationary phase was an Ac-
quity UPLC BEH C18 column (100  2.1 mm, 130-Å pore, 1.7-	m
particle; Waters), and the mobile phase was set at 0.5 ml/min through
a binary gradient elution using a saline buffer (20 mM ammonium
acetate, pH 5.6) and acetonitrile, as follows: time 0 to 1.1 min,
isocratic 100% saline buffer; 1.1 to 5 min, gradient from 0 to 13.6%
acetonitrile; 5 to 5.1 min, gradient from 13.6 to 100% acetonitrile; 5.1
to 6.1 min, isocratic 100% acetonitrile; and 6.1 to 7.2 min, isocratic
100% saline buffer. Detection of the eluate components was per-
formed using multiple reaction monitoring, with positive electrospray
mode with the following m/z transitions: 244.8  113.0 for uridine
(12-V cone voltage, 10-eV collision energy) and 136.8  110.1 for
hypoxanthine (32-V cone voltage, 18-eV collision energy). Identifi-
cation of the compounds was based on retention time and ion transi-
tions. Calibration curves made with aqueous standards were processed
in parallel, and concentrations were obtained from interpolation of the
peak areas using Target Lynx software (Waters). The levels of uridine
and hypoxanthine were analyzed in serum of nine human subjects at
both ground level and high altitude.
Statistical analysis. Two-tailed P values of duodenal targets were
calculated by either ANOVA or Mann-Whitney test. Two-tailed P
values between groups of serum analytes were assessed by paired
t-test, using Graph Pad Prism 5 software (La Jolla, CA). To test for
correlations between serum (and/or tissue) analytes and the expression
levels of SLC in the duodenum, the data were logarithmically trans-
formed and measured by a linear regression analysis using IBM SPSS
Statistics Version 21. Graphs were plotted using GraphPad Prism
version 5.00 for Windows (GraphPad Software).
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Fig. 1. mRNA expression levels of duodenal Solute carrier (SLC) transporters in healthy human subjects exposed to high-altitude hypoxia. All available duodenal
specimens from ground level of Zurich (ZRH; n  27), 4,555 m above sea level at day 2 (CM2; n  18) and at day 4 (CM4; n  21) were analyzed by RT-PCR.
The mRNA expression levels of implicated SLC transporters were assessed vs. villin-1, each specimen measured in duplicates. ASBT, apical sodium-dependent
bile acid transporter; CNT, concentrative nucleoside transporters; ENT equilibrative nucleoside transporter; OATP, organic anion transporting polypeptide;
OCTN, organic cation transporter; PEPT, peptide transporter; SERT, serotonin transporter. Statistical analysis was performed using Kruskal-Wallis test with
Dunn’s multiple comparison test: *P  0.05; **P  0.01; ***P  0.001; ****P  0.0001.
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High-altitude hypoxia changes the expression levels of SLC
transporters in human duodenum. To investigate the impact of
hypoxia on SLC expression in vivo, we quantified the mRNA
expression levels of implicated transporters in human duodenal
specimens obtained from healthy subjects after ascent to high
altitude. Interestingly, the mRNA expression levels of tested
duodenal SLCs were changed at high altitude compared with
the near sea levels of Zurich. Specifically, the mRNA levels
of apical sodium-dependent bile acid transporter (ASBT),
OATP2B1, OCTN2, concentrative nucleoside transporters 1
and 2 (CNT1 and CNT2), OCTN1, PEPT1, and SERT were
significantly decreased upon exposure to high-altitude hypoxia
(Fig. 1) The levels of ENT2 and GLUT1 were not changed
significantly; however, in the case of latter we observed a trend
towards increased expression over time (Fig. 1). Because some
individuals suffered from AMS, the entire cohort was subdi-
vided according to the use of dexamethasone (44) (also see
Human subjects and exposure to high-altitude hypoxia). We
observed that changes in the expression of SLCs were gener-
ally independent of dexamethasone treatment (Table 1). Nota-
bly, mRNA levels of OCTN1 increased significantly compared
with basal levels but only in the control group (Table 1).
High-altitude exposure changes the expression levels of pro-
and anti-inflammatory cytokines in human duodenum. To in-
vestigate the potential link of hypoxia-induced changes in SLC
levels and intestinal inflammation, we also screened for the
expression levels of proinflammatory cytokines along with
important targets of innate immunity. Hypoxia significantly
increased duodenal mRNA levels of proinflammatory cyto-
kines IFN- and IL-6 (both 2.5-fold) detected 2 days after
ascend to high altitude but only in subjects suffering from
AMS (Table 1). This effect was attenuated on day 4, i.e., after
the administration of dexamethasone that decreased the expres-
sion levels of all other proinflammatory targets, even below the
basal levels (Table 1). Interestingly, high-altitude hypoxia also
affected the mRNA expression levels of regulatory T-cell
markers, such as IL-17, ROR-, and Foxp3. Hypoxia-mediated
induction of IL-17 was independent of AMS; however, the
mRNA levels of Foxp3 were markedly different between these
two subgroups (Table 1).
High-altitude exposure modulates the serum levels of pro-
inflammatory and anti-inflammatory mediators. To investigate
if the observed changes in duodenum are accompanied by the
differences in the release of immunologically relevant media-
tors including substrates of SLC transporters, we next analyzed
serum samples before and after exposure to high altitude. We
detected higher levels of proinflammatory mediators, namely
IFN-, IL-8, macrophage inflammatory protein-1 (MIP-1),
and matrix metalloproteinase-2 (MMP-2), in serum of all
subjects upon elevation to high altitude (Fig. 2). In addition, we
also detected higher levels of anti-inflammatory IL-10, which
increased in the time of exposure to hypoxia. Conversely, the
levels of CCL-2 were significantly lower but only at day 4 (Fig.
2), which was in concert with the inhibitory effect of hypoxia
on the production of this chemokine in alveolar macrophages
(47). Next, to investigate the functional consequences of
changes in the expression of intestinal transporters, we mea-
Table 1. Impact of high-altitude hypoxia on the expression of SLC transporters and inflammatory markers in human
duodenum
High-Altitude Hypoxia
Healthy (n  7) AMS (n  9)
Duodenum () Day 2 () Day 4 () Day 2 Dex Day 4 P Value
SLC transporters
ASBT 0.40 (0.14)† 0.68 (0.43)* 0.46 (0.16)‡ 0.37 (0.15)‡ 0.0100
CNT 1 0.62 (0.35)* 0.60 (0.48)* 0.68 (0.20)† 0.51 (0.25)* 0.1281
CNT 2 0.44 (0.21)* 0.60 (0.44)* 0.57 (0.21)* 0.48 (0.19)* 0.3679
ENT 2 0.70 (0.33) 1.03 (0.93) 1.32 (0.86) 1.63 (1.51) 0.5359
GLUT 1 0.85 (0.45) 1.01 (0.55) 1.14 (0.54) 1.56 (1.15) 0.4279
OATP2B1 0.62 (0.17)‡ 0.82 (0.26)* 0.71 (0.26)* 0.76 (0.24)* 0.7953
OCTN 1 1.12 (0.83) 3.47 (2.82)* 0.77 (0.44) 1.50 (1.31) 0.2561
OCTN 2 0.82 (0.41) 0.86 (0.13)* 0.86 (0.31) 1.17 (0.45) 0.0398
PEPT 1 0.53 (0.39)* 0.90 (0.53) 0.65 (0.22)* 0.80 (0.34) 0.2120
SERT 0.87 (0.48) 0.98 (0.57) 0.86 (0.27) 0.75 (0.36) 0.5808
Cytokines
IFN- 0.78 (0.38) 1.02 (1.01) 2.52 (2.20)* 0.54 (0.41)† 0.0189
IL-6 0.83 (0.89) 0.40 (0.34)* 2.52 (1.85)* 1.43 (1.42) 0.0361
IL-10 1.16 (0.23) 0.45 (0.21)* 1.56 (0.62)* 0.75 (0.45) 0.0143
T cells
IL-17A 2.41 (0.71)* 1.26 (1.48) 2.22 (0.75)† 0.66 (0.50) 0.0447
ROR- 1.52 (1.33) 0.42 (0.18)* 0.66 (0.24)* 0.52 (0.26)* 0.1124
Foxp3 0.96 (0.51) 1.10 (0.78) 0.70 (0.40)* 0.32 (0.15)* 0.0334
Numbers in parentheses represent  SD. Duodenal biopsies from healthy subjects were analyzed at the beginning of the study [Zurich (ZRH)] as well as 2
and 4 days after ascent to high altitude. The mRNA expression levels of solute carrier (SLC) transporters were determined vs. villin-1 and relevant
proinflammatory cytokines relative to mRNA expression levels of -actin. The basal expression levels in both control (n  7) and acute mountain sickness
(AMS)/dexamethasone (Dex)-treated (n  9) groups were set to 1 for each individual at the ground level of Zurich and displayed as a fold difference as compared
with the basal levels. The effect of Dex in AMS group was assessed by comparing the mRNA levels before (day 2; CM2) and after (day 4; CM4) administration
of the drug (last column; P values). ASBT, apical sodium-dependent bile acid transporter; CNT, concentrative nucleoside transporter; ENT, equilibrative
nucleoside transporter; OCTN, organic cation transporter; OATP, organic anion transporting polypeptide; PEPT, peptide transporter; SERT, serotonin transporter.
Statistical analysis was performed using Friedman test with Dunn’s multiple comparison test: *P  0.05; †P  0.01; ‡P  0.001 vs. ZRH levels.
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sured the levels of SLC substrates in serum of the same human
subjects exposed to high-altitude hypoxia. Interestingly, the
amounts of serotonin [5=-hydroxytryptamine (5=-HT)], a sub-
strate of SERT, significantly increased at day 4. A different
trend was observed for uridine, which is a substrate of nucle-
oside transporter CNTs and ENTs (Fig. 2). The serum levels of
hypoxanthine, which is a substrate of ENT2, did not change
upon elevation to high altitudes, and this observation was
consistent with unchanged mRNA levels of this transporter in
the duodenal tissue (Fig. 1 and Table 1). The serum levels of
Table 2. Effect of high-altitude hypoxia on serum levels of inflammatory mediators and biologically active SLC substrates in
humans
Serum
Healthy (n  7) AMS (n  9)
P Value
ZRH High Altitude ZRH High Altitude
() Day 0 () Day 2 () Day 4 () Day 0 () Day 2 Dex Day 4
Cytokines and Chemokines
IFN- 1.9 (0.53) 2.8 (1.08) 2.6 (0.82) 1.6 (0.77) 2.6 (0.66)* 2.2 (0.74) 0.1946
IL-8 5.9 (0.93) 5.0 (1.22) 6.5 (1.68) 4.9 (1.03) 6.9 (1.37)† 4.9 (2.03) 0.0710
IL-10 1.9 (0.50) 2.9 (0.88) 3.6 (1.13)* 2.1 (0.53) 2.9 (1.29) 3.1 (0.99)† 0.7869
IL-18 134 (18.7) 119 (28.0) 117 (20.5)* 99 (25.1) 112 (38.9) 100 (36.2) 0.0076
CCL-2 80.3 (12.3) 68.5 (10.0)* 67.3 (7.2)* 67.4 (11.4) 72.7 (8.3) 44.4 (7.0)† 0.0001
MIP-1 128 (37.6) 128 (37.6) 139 (42.4) 100 (44.1) 137 (45.9)* 88.9 (36.6) 0.0040
MMP-2 718 (50.0) 758 (104.4) 795 (92.6) 634 (97.2) 736 (91.8)† 685 (120.0) 0.3544
Other
5=-HT 126 (97) 162 (102) 203 (97)* 126 (78) 112 (40) 136 (50) 0.2755
Urd 3.8 (1.0) 3.4 (1.1) 3.2 (0.6) 3.9 (0.8) 2.6 (0.9)‡ 2.5 (0.6)‡ 0.5502
HPX 0.35 (0.2) 0.33 (0.15) 0.35 (0.22) 0.33 (0.19) 0.23 (0.12) 0.32 (0.17) 0.0969
tBA 10.3 (4.1) 15.2 (6.0) 7.9 (6.4) 7.8 (3.4) 7.6 (6.1) 13.9 (8.7) 0.1439
Numbers in parentheses represent  SD. Serum samples from healthy subjects were analyzed at the beginning of the study at the level of Zurich (ZRH) as
well as on day 2 (CM2) and day 4 (CM4) after assent to high altitude (Capanna Margheritta; 4,555 m above sea level). Effect of Dex (P values) in the AMS
group was assessed by comparing the values before (CM2) and after (CM4) the administration of Dex. The levels of cytokines and chemokines in serum are
displayed in pg/ml The levels of 5=-hydroxytryptamine (5=-HT) are displayed in ng/ml. Total bile acids (tBA), uridine (Urd), and hypoxanthine (HXT) levels
are expressed in 	M. MIP-1, macrophage inflammatory protein-1; MMP-2, matrix metalloproteinase-2. Statistical analysis was performed using Friedman test
with Dunn’s multiple comparison test: *P  0.05; †P  0.01; ‡P  0.001 vs. ZRH levels.
IFN- γ                                    IL-8                                 IL-10                                 IL-18                                CCL-2                               MMP-2
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Fig. 2. Effect of high-altitude hypoxia on serum levels of inflammatory mediators and biologically active compounds in humans. Serum samples from healthy
subjects were analyzed at the beginning of the study at the level of Zurich (ZRH) as well as on day 2 (CM2) and day 4 (CM4) after assent to high altitude
(Capanna Margheritta; 4,555 m above sea level; n  16). MMP-2, matrix metalloproteinase-2; MIP-1, macrophage inflammatory protein-1; 5=-HT,
5=-hydroxytryptamine; Urd, uridine; HXT, hypoxanthine; tBA, total bile acids. Statistical analysis was performed using Kruskal-Wallis test with Dunn’s multiple
comparison test: *P  0.05; **P  0.01.
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bile acids (substrates of ASBT) were not altered upon exposure
to high-altitude hypoxia. To evaluate the influence of AMS and
concomitant dexamethasone treatment on the serum levels of
these mediators, we subdivided our cohort in according to the
presence or absence of AMS symptoms (Table 2). Similar to
the anti-inflammatory effect observed in duodenal tissues,
dexamethasone effectively decreased the levels of all proin-
flammatory targets measured, which was correlated with the
remission of AMS symptoms in this subgroup of subjects.
Conversely, despite some increasing trends in healthy group,
we did not observe any significant changes in proinflammatory
targets. This observation was consistent with the absence of
high-altitude sickness symptoms among these subjects. More-
over, in the control group we observed a significant decrease in
the levels of the proinflammatory cytokine IL-18 and chemo-
kine CCL-2, suggesting that these subjects developed an anti-
inflammatory response when exposed to high altitude, which
could also be supported by increased levels of anti-inflamma-
tory IL-10 (Table 2). Increased levels of serotonin, known to
inflict a broad range of physiological effects in the gut (20),
were significantly higher only in control group. Interestingly,
serum levels of uridine, known to exert an anti-inflammatory
effect in animal models of lung inflammation (16), were
significantly lower only in AMS/dexamethasone group (Table
2). The levels of bile acids did not change significantly in any
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Fig. 3. Effect of hypoxia on the mRNA levels of SLC
transporters and proinflammatory signaling in human
intestinal cells. A: mRNA levels of ENT2, OCTN 2,
and SERT are decreasing during the oxygen depriva-
tion in vitro. T84 cells grown on Transwells were
incubated in 1% O2 for different time points. The
results represent mean values of 3 independent exper-
iments each measured in triplicates relatively to the
basal levels of a target vs. -actin and set to 1 for each
experiment. Error bars indicate SE. *P  0.05; **P 
0.01; ***P  0.001 vs. normoxic cells. B: protein
levels of OCTN2, ENT2, and SERT are decreased in
response to hypoxia in vitro. The protein expression
levels of SLCs were assessed by Western blotting.
-Actin was used as a loading control. C: Western
blotting analysis of hypoxia-inducible factor-1 (HIF-
1) protein in hypoxic T84 cells. D: immunofluores-
cence analysis of HIF-1 and HIF-2 proteins in T84
cells. Size bar  20 	m. E: hypoxia triggers proin-
flammatory signaling in intestinal epithelial cells
(IECs) in vitro. The activation of ERK was assessed
by Western blotting. F: hypoxia induces production of
IL-8 mRNA. The results represent mean values of 3
independent experiments each measured in triplicates
relatively to the basal levels of a target vs. -actin and
set to 1 for each experiment. Error bars indicate SE.
Statistical analysis was performed using repeated-
measures ANOVA with Tukey’s multiple comparison
test: *P  0.05 vs. normoxic cells.
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Hypoxia decreases the expression levels of SERT, ENT2,
and OCTN2 transporters and activates proinflammatory sig-
naling in human IECs in vitro. To confirm an observed effect
of hypoxia on the expression levels of SLC transporters ob-
served at high altitudes in human subjects, we incubated
human intestinal epithelial T84 cells in humidified atmosphere
containing 1% O2 over a period of 3 days and subsequently we
monitored the mRNA expression levels of specific subset of
SLCs involved in the transport of nutrients, hormones, and
biologically active compounds in the intestine that were re-
ported to be altered upon intestinal inflammation in humans
(52). We observed that hypoxia decreased the levels of carni-
tine transporter (OCTN2) and SERT mRNAs (Fig. 3A). The
expression levels of ENT2 were also decreased. Concerning
other SLCs of potential importance to inflammatory responses
in the gut, we observed only transient trends in mRNA levels
of CNT1 and CNT2, PEPT1, OATP2B1, and OCTN1. Con-
sistent with mRNA data for ENT2, OCTN2, and SERT, we
observed decreased protein levels of these three SLCs 72 h
after induction of oxygen deprivation in hypoxic chambers
(Fig. 3B). Western blotting analysis confirmed an increased
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Fig. 4. Effect of HIF1/2 and ERK1/2 inhibitors on hypox-
ia-induced changes in SLCs mRNA levels. T84 cells
grown on Transwells were incubated in either in 20 or
in 1% of O2 for 72 h in the presence or absence of
inhibitors of ERK (FR180204) and HIFs (FM19G11).
The results represent mean values of 3 independent ex-
periments each measured in triplicate. A: ENT2. B:
OCTN2. C: OATP2B1. D: SERT. E: IL8. F: GLUT1.
Statistical analysis was performed using repeated-measures
ANOVA with Tukey’s multiple comparison test: *P  0.05;
**P  0.01; ***P  0.001 vs. untreated cells.
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of hypoxia (Fig. 3C). This was confirmed by immunofluores-
cence, which revealed an increase of HIF-1 and -2 proteins
48 h after induction of hypoxia (Fig. 3D), targets expected to
be upregulated by hypoxia. Because of the known cross talk
between hypoxia and proinflammatory signaling (9, 14, 22),
we next tested if the observed hypoxia-induced changes in SLC
levels are accompanied by changes in proinflammatory signal-
ing pathways in human IECs. Interestingly, hypoxia activated
ERK signaling at 72 h (Fig. 3E) and stimulated production of
IL-8 mRNA (Fig. 3F).
Hypoxia-induced late effects on the expression of SLCs are
independent on HIF and ERK signaling in vitro. To investigate
the role of HIF and ERK signaling in the regulation of the
expression of ENT2, OATP2B1, OCTN2, and SERT, next we
induced hypoxia in IECs in the presence of pharmacological
inhibitors of these pathways. Interestingly, we did not observe
any significant effects on the expression levels of these SLCs
72 h after induction of hypoxia (Fig. 4, A-D), although both
ERK and HIF classical targets, namely IL-8 and GLUT-1, were
clearly affected (Fig. 4, E and F, respectively).
Hypoxia decreases the expression of SLCs during early time
points in vitro. Until now we did not observe any changes in
the expression of SLCs early (0–4 h) when we incubated cells
in 1% O2 atmosphere but mostly in the late time points (24–72 h).
Based on the absence of the early response, it was difficult to
exclude that the observed effects of hypoxia on the expression
of SLCs were only secondary and/or unspecific. To investigate
if oxygen deprivation indeed triggers specific changes in SLC
expression, we incubated T84 cells in a more steep oxygen
gradient (O2%) allowing therefore a more rapid hypoxic sig-
naling to occur and monitored the changes over the first 4 h.
Western blotting analysis showed that the increase of protein
levels of HIF-1 was achieved already after 2 h (Fig. 5A).
Consistent with the previous observations (Fig. 3 and 4), we
detected a decrease in expression levels of all SLC tested (Fig.
5B). The downregulation was statistically significant for










































































































































Fig. 5. Effect of hypoxia on SLCs mRNA levels in early time points. T84 cells
grown on Transwells were incubated in 0.2% of O2 for 2 and 4 h. A: Western
blotting analysis of HIF-1 protein. B: relative mRNA expression levels of
SLC transporters. The results represent mean values of 3 independent exper-
iments each measured in triplicate. Statistical analysis was performed using
repeated-measures ANOVA with Tukey’s multiple comparison test: *P 
































































Fig. 6. The impact of CoCl2 on the cell viability of human IECs T84. A: cell
viability was determined by measurement of ATP content in growing T84
cells. B: cell toxicity was determined by LDH release. Results show mean
values of 2 independent experiments measured in triplicate. Triton X-100
(0.1%) was used as a negative control of cell viability.
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levels of GLUT-1, a target gene of HIF-1, were increased,
confirming the specificity of hypoxic signaling.
Chemically induced hypoxia triggers downregulation of in-
testinal SLC genes. Because of hypoxia-induced trends in SLC
expression levels were only transient for some SLCs, we next
induced hypoxia chemically by incubating T84 cells with
cobalt chloride (CoCl2), a compound that prevents PHD-
mediated degradation of HIFs (55). Because cobalt chloride
could potentially affect cell viability, we have tested this
compound on T84 cells (Fig. 6). Increase concentrations of
CoCl2 had only minimal effect on cells viability as measured
by ATP content in cell monolayers (Fig. 6A). When LDH
release was assessed, a standard toxicity assay, only minor
fluctuations were detected (Fig. 6B), confirming an absence of
overall harmful effect. With regard to the mRNA expression
levels of SLCs, CoCl2 induced a time- and concentration-
dependent significant decrease of CNT1, PEPT1, OCTN2,
OATP2B1, and SERT (Fig. 7) expression in T84 cells. The
mRNA expression levels of CNT2, ENT2, and OCTN1 were
also significantly decreased but mostly at early time points and
at high concentrations of CoCl2. Simultaneously, chemically
induced hypoxia increased the levels of GLUT1 mRNA, con-
firming the HIF-1-specific signaling (Fig. 7I). To further in-
vestigate these findings, CoCl2 was next added to Caco2 cells,
another human IEC line, in a time- and a concentration-
dependent manner, similar to the previous experiments with
T84 cells. Interestingly, the mRNA levels of SLCs expressed in
Caco2 were also decreased mostly with a minimum between 8
and 24 h after treatment, but it was not the case for all the tested
SLCs (Fig. 8). Notably, the mRNA levels of ASBT, exclu-
sively expressed in this particular cell line, were also decreased
in time (Fig. 8A), which was in a strong concert with in vivo
data (Fig. 1 and Table 1). Similar to T84, mRNA levels of
GLUT-1 expressed in Caco2 were increased in both a time-
dependent and concentration-dependent manner (Fig. 8I)
IL-6 and IFN- potentiates hypoxia-induced decrease of
nucleoside and serotonin transporters in IECs. To assess the
potential impact of proinflammatory mediators on mRNA
levels of SLC genes during hypoxia, we incubated T84 cells in
hypoxic chambers and stimulated them subsequently with IL-6
and IFN-, two cytokines that were elevated in both serum and
tissue of individuals suffering from AMS (23). Before this we
tested if the addition of proinflammatory cytokines, especially
during hypoxia, would affect cell viability. As anticipated,
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Fig. 7. Effect of chemically induced hypoxia on mRNA expression levels of SLC transporters in human IEC line T84. T84 cells were stimulated with different
concentrations of CoCl2 and harvested at different time points. The mRNA expression levels of implicated SLC transporters were assessed by RT-PCR in 4
independent experiments each measured in triplicates relatively to the basal levels of a target vs. -actin and set to 1 for each experiment. A: CNT1. B: CNT2.
C: ENT2. D: PEPT1. E: OCTN1. F: OCTN2. G: OATP2B1. H: SERT. I: GLUT1. Error bars indicate SE. Statistical analysis was performed using
repeated-measures ANOVA with Tukey’s multiple comparison test: *P  0.05; **P  0.01; ***P  0.001 vs. normoxic cells.
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hypoxia alone decreased viability of T84 cells for 20% as
measured by ATP content (Fig. 9A). Interestingly, the presence
of IFN-, but not IL-6, decreased cell viability further of
10%. To investigate if these effects were due to changes in
cell division rate, we performed cell proliferation assays using
the same conditions. Surprisingly, we detected a marked de-
crease of proliferating cells during hypoxia compared with
normoxia (Fig. 9B). These changes were independent on the
addition of IL-6 and/or IFN- but only during oxygen depri-
vation. During normoxia, implicated proinflammatory cyto-
kines inhibited cell proliferation only when added together and
the effect on cell proliferation was comparable to hypoxia
alone (Fig. 9B). The assessment of RNA content in the treated
samples revealed that hypoxia indeed decreases cell prolifera-
tion rate (Fig. 9C), but this effect was rather independent on the
addition of cytokines. Conversely, the assessment of cytotox-
icity by LDH assay confirmed that hypoxia has some toxic
effect on cells, but this was not changed upon addition of
cytokines (Fig. 9D). Stimulation with either IL-6 and/or IFN-
during hypoxia had overall the same effect on the expression
levels of most of the tested SLCs compared with normoxia but,
in the case of some targets, to a greater extent (Fig. 10).
Specifically, this was the case for CNT2, OATP2B1, and
SERT. Stimulation with IL-6 and IFN- had a markedly
different outcome on the expression levels of OCTN1 and
OCTN2 compared with normoxia. Little or no effect was
observed in case of ENT2 and GLUT-1, which were differently
affected by hypoxia alone. Last, IFN- had a dramatically
stronger effect on the production of ICAM-1 mRNA during
hypoxia compared with normoxia (Fig. 10). Since colonic T84
cells were not an ideal system to confirm in vitro effects of
hypoxia in human duodenum, we next tested if hypoxia
changes mRNA levels of implicated SLCs in the intestinal cells
from duodenum. To test this, we stimulated human duodenal
cell line Hutu80 in a similar fashion as in our previous
experiments. Surprisingly, this cell line expressed detectable
amounts of only two transporters from our panel, namely
ENT2 and OCTN2; however, incubation in hypoxic environ-
ment with or without addition of proinflammatory cytokines
resulted in similar effects on the mRNA levels of these trans-
porters as in colonic T84 cells (Fig. 11A) An increased expres-
sion of HIF-1-specific target COX-2 confirmed that hypoxic















































































































































































































































































































































Fig. 8. Effect of chemically induced hypoxia on mRNA expression levels of SLC transporters in human IEC line Caco2. Caco2 cells were stimulated with
different concentrations of CoCl2 and harvested at different time points. The mRNA expression levels of implicated SLC transporters were assessed by RT-PCR
in four independent experiments each measured in triplicates relatively to the basal levels of a target vs. -actin and set to 1 for each experiment. A: ASBT.
B: CNT2. C: CNT2. D: ENT2. E: OATP2B1. F: OCTN1. G: OCTN2. H: SERT. I: GLUT1. Error bars indicate SE. Statistical analysis was performed using
repeated-measures ANOVA with Tukey’s multiple comparison test: *P  0.05; **P  0.01; ***P  0.001 vs. normoxic cells.
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signaling was effectively induced. In concert with these obser-
vations, CoCl2-induced hypoxia decreased the mRNAs of both
ENT2 and OCTN2 in a time- and a concentration-dependent
manner (Fig. 11B), essentially confirming the effects observed
in colonic cell lines (Figs. 7 and 8) at least for these two SLCs.
Serum levels of inflammatory mediators correlate with the
expression of specific SLCs in human duodenum. To test for
potential correlation between implicated serum analytes and
duodenal mRNA levels of SLCs, we performed regression
analysis of all human samples obtained from ground level and
at high altitude. As partially expected, we found a significant
correlation between the expression of CNT1 and serum levels
of uridine, which is a substrate of this transporter (Fig. 12A).
Interestingly, we found inverse correlations between serum
levels of IFN- and mRNA expression levels of ASBT and
ENT2 (Fig. 12, B and C, respectively). In addition, we also
observed inverse, statistically significant correlations between
serum levels of IL-10 and mRNA expression levels of ASBT
and CNT1 (Fig. 12, D and E, respectively).
DISCUSSION
Oxygen sensing is one of the most important mechanisms
controlling the body metabolism in states of health and disease.
In the present study, we have identified a novel pleiotropic
effect of hypoxia on the intestinal physiology, involving a set
of SLC genes. Low oxygen levels and/or increase of HIF
proteins were correlated with a decrease in mRNA levels of
several intestinal SLC in vitro. Most importantly, our study
demonstrates the existence of this physiological phenomenon
in human duodenum upon exposure to high-altitude hypoxia.
Furthermore, decreased expression levels of duodenal SLCs
are accompanied by changes of systemic levels of biologically
active compounds, such as serotonin and uridine. Last, but not
least, we show that the levels of circulating IFN-, MMP-2,
and IL-10 are elevated upon ascent to high altitude in humans,
an observation not reported earlier.
Previously, we reported that mRNA expression levels of
selected SLC transporters in IBD intestine were upregulated
upon inflammation (52). Here, we report that hypoxia de-
creased mRNA levels of SERT in both human duodenum in
vivo (Fig. 1 and Table 1) and in human intestinal cells in vitro
(Figs. 3, 4, and 5). These effects were correlated with elevated
systemic levels of serotonin (5=-HT) (Table 2), which is mainly
produced by enterochromaffin cells acting as oxygen sensors in
the gut (28). Higher levels of 5=-HT are typically associated
with pulmonary hypertension and hypoxia (1, 12), but it is not
clear at this point if this effect elicits an overall harmful or
beneficial effects in human duodenum, since next to its rather
proinflammatory role during colitis, serotonin can also promote
mucosal growth and intestinal motility (20). Consistently,
stimulation with proinflammatory cytokines, which were up-
regulated both locally and systemically during high-altitude
hypoxia (Tables 1 and 2 and Fig. 2), resulted in a profound
decrease in the expression levels of SERT, even in normoxic
conditions (Fig. 10). Based on these results we postulate that
hypoxia-mediated downregulation of SERT in duodenum, which
represents serotonin recycling system of serotonin, could contrib-
ute to the observed rise in serum concentration of this hormone.
We report that the expression levels of carnitine transporter


































































































































































Fig. 9. The effect of IFN- and IL-6 on the
cell viability and proliferation during nor-
moxia and hypoxia. A: cell viability was
determined by measurement of ATP content
in growing T84 cells. B: cell proliferation is
decreased during hypoxia, but the addition
proinflammatory cytokines does not influ-
ence this effect. C: yield of RNA isolation is
lower in hypoxic cells compared with nor-
moxic cells. D: hypoxia alone, but not to-
gether with IFN- and IL-6, induces cell
toxicity of T84 cells. Triton X-100 (0.1%)
was used as a negative control of cell viabil-
ity. AU, arbitrary units.
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num and in the IECs in vitro (Fig. 1 and Table 1; Figs. 3–7,
respectively). This observation is supported by earlier studies
conducted in placenta both in vitro and in vivo (8, 36). Because
L-carnitine was reported to have an anti-inflammatory effect
during colitis (18, 45), it can be anticipated that a decrease in
the expression of OCTN2 could have important, long-term
consequences for gut physiology as demonstrated in knockout
animal models (43) as well as IBD patients (38, 52). Of note,
therapeutic administration of dexamethasone increased the
expression levels of OCTN2, which was on one hand corre-
lated with attenuation of AMS symptoms at high altitude and
on the other strongly supported by positive influence of ste-
roids on the expression of this transporter accompanied by their
overall therapeutic effect in IBD patients (52).
In addition, we observed that hypoxia-induced changes in
nucleoside transporters markedly differ between in vitro and in
vivo analyses. Whereas both the mRNA and protein expression
levels of ENT2 were significantly reduced in in vitro experi-
ments, there was only a small decrease observed in vivo (Figs.
1 and 3). Concerning the expression levels of CNTs, we
observed a strong decreasing effect of hypoxia in duodenum,
which could be supported by our in vitro data (Figs. 3, 5, 7, and
8). The hypoxia-mediated impact on CNTs became visible,
when we detected decreasing amounts of uridine in serum of
all human subjects exposed to high-altitude hypoxia (Figs. 1, 2,
and 12 and Table 2). This was in a strong concert with
observations that hypoxia not only inhibits CNT2-mediated
uptake of this nucleoside in neuronal cells but also reduces the
expression levels of CNT2 in the ischemic brain (33). Based on
the fact, that uridine is known to have anti-inflammatory
effects in animal models of lung inflammation, as well as
protective function in hypoxia/ischemia-induced damage on
vascular and central nervous systems (6, 10, 16), it can be
concluded that human subjects exposed to high-altitude hyp-
oxia, especially those suffering from AMS, may indeed be
affected by the drop in physiological levels of this nucleoside.
It would be tempting to speculate that hypoxia-induced down-
regulation of CNTs could either act as a protective mechanism
to prevent from scavenging uridine back to the intestinal tissue
or it would be an effect directly linked to limited intestinal
absorption of nucleosides. Of note, the levels of hypoxanthine,
an endogenous substrate of ENTs, were not changed signifi-
cantly (Fig. 2 and Table 2), which coincided with unchanged
expression levels of ENT2 in duodenum (Fig. 1 and Table 1).
It is tempting to speculate if other nucleosides, which have
been reported to play an important role in mediating responses
during intestinal inflammatory hypoxia, such as adenosine (15,







































































































































































































































































































Fig. 10. Effect of IFN- and IL-6 on mRNA levels of SLCs in the IECs during hypoxia. T84 cells grown on Transwells were incubated in either 1 or 20% O2
for 72h. Both cytokines were added to the basolateral chambers 24 h before harvesting. To confirm the specificity of IFN- -mediated signaling, ICAM1 mRNA
levels were assessed. The results represent mean values of 3 independent experiments, each measured in triplicates relatively to basal mRNA expression levels
set to 1 for untreated normoxic cells in each experiment. Error bars indicate SE. *P  0.05; **P  0.01; ***P  0.001 vs. normoxic cells.
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earlier (41). Further studies are required to investigate this
hypothesis.
It is still unknown if any of HIFs are directly responsible for
the observed decrease in mRNA levels of implicated transport-
ers by repressing transcription of SLC genes. The results
obtained using selective inhibitor of HIFs do not favor this
hypothesis (Fig. 4), but stimulation with CoCl2 showed that
HIF-1 could play a role in this repression (Figs. 6, 7, and 11).
To provide more insight into possible roles of HIFs in this
phenomenon, one should attempt to employ more complex and
sophisticated systems of studying transcriptional control me-
diated by HIFs, such as knockdowns and promoter binding
assays in combination with more potent and selective inhibi-
tors. The potential scope of the investigation would aim at the
involvement of also other components of hypoxic signaling
upstream of HIF-1, such as PHDs. Nevertheless, it could not
be excluded that observed decrease in SLC mRNA levels is a
result of a hypoxia-induced depletion and/or limited availabil-
ity/activity of pivotal transcription factors responsible for main-
tenance of basal levels of these particular transcripts. For
OATP2B1 and OCTN2 this could be CREB-binding protein or
any member of p300 family of transcription factors, which on
one hand can bind to the promoter sites of their target genes
and on the other mediate HIF-specific effects. Another mech-
anism of action could involve a cross talk with proinflamma-
tory signaling at the level of transcriptional control, since many
of implicated SLC genes bind transcription factors linked to the
implicated pathways, such as STAT1, NF-B, and AP-1.
However, a highly probable mechanism of repression of SLC
mRNA levels could involve a hypoxia-mediated inhibition of
transcription preinitiation complex by negative cofactor 2
(NC2), a phenomenon related to the control of energy demand
on a cellular level, which was reported earlier by Denko et al.
(11). These issues will need to be addressed in the near future.
The direct consequences of the observed changes in intesti-
nal SLCs at the systemic level are still largely unknown. It has
been reported previously that animals transferred to high alti-
tude increase the mass of both heart and lungs, while the mass
of the intestines significantly decreases (25). In support of this,
our findings indicate that intestinal absorption may be affected,
since the expression levels of most of tested SLCs were
decreased upon exposure to hypoxia. Interestingly, Aeberli et
al. (2) observed that among the same individuals elevation to
high altitude triggered a significant weight loss with a simul-
taneous decrease in energy intake, which was not related to the
changes in the release of gastrointestinal hormones controlling
appetite. The results presented within this article suggest that



































































































































Fig. 11. Effect of hypoxia on mRNA expression levels of ENT2 and OCTN2 in human duodenal Hutu80 cell line. A: Hutu80 cells were incubated in either
normoxic (20% O2) or hypoxic (1% O2) environment for 4 days with or without human recombinant IFN-. The mRNA expression levels of SLCs were
determined by RT-PCR. Graphs show the results from 2 independent experiments, each measured in duplicate. Error bars indicate SE. B: chemically induced
hypoxia decreases the mRNA expression levels of OCTN2 and ENT2 in Hutu80. The graphs show the results of a single experiment measured in duplicate.
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decreased intestinal absorption of nutrients, drugs, as well as
biologically active mediators of systemic homeostasis, such as
L-carnitine, nucleosides, serotonin, and possibly many others.
This effect would be a direct consequence of hypoxia-mediated
active repression of genes, which can be dispensable for cells
under oxygen deprivation (11).
Altogether, our results strongly suggest that both local and
systemic oxygen levels should be considered not only impor-
tant for intestinal absorption but also as pivotal for immune
responses in healthy intestine. This has been supported by
studies of intestinal pathological conditions, such as IBD (21,
22, 26). Last, but not least, we reported that high altitude
induces production of proinflammatory cytokines in human
duodenum and confirmed that hypoxia triggers proinflamma-
tory signaling in the IECs in vitro, which were supported by
findings of Taylor et al. (46). Changes in both pro- and
anti-inflammatory cytokines were coinciding with changes in
the levels of regulatory T-cell markers, such as Foxp3, IL-17A,
and ROR- (Table 1), which in turn may hint at the misbalance
in immunoregulation occurring in hypoxic duodenum. Inter-
estingly, the link between systemic levels of pro- and anti-
inflammatory mediators and the expression levels of duodenal
SLCs became evident when significant correlations between
the members of these two groups were found (Fig. 12). It is still
a question of a debate what the exact role of nucleoside and
bile acid transporters in mediating inflammatory signals in
hypoxic duodenum is; however, our earlier study in IBD
patients had already implied such function (52). The observa-
tions of current study could also provide clues for the increased
incidence of flares in IBD patients traveling to high altitude, as
reported recently by our group (49). Our study has also limi-
tations, e.g., relatively small number of human subjects, lack of
dexamethasone randomization, and lack of functional data on
the effect of hypoxia on transporter activity as well as the
absence of in-depth investigation on mechanistic and molecu-
lar levels. These issues need to be addressed during the future
studies, where we will aim at identification of therapeutically
relevant molecular mechanisms, which operate in IBD patients
during exposure to hypoxic environment.
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Statistical significance was determined by linear regression analysis. Ct, change in critcal threshold.
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